跳至主要内容
临床试验/NCT04244812
NCT04244812Unknown不适用

The Microcirculatory Characteristics of the Heart and Lung Meridians: A Study of CSAP Patients and Healthy Adults

Zhejiang Chinese Medical University1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2020年2月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
120
试验地点
1
主要终点
Change from baseline blood perfusion units

研究概览

简要总结

This study is designed to detect the microcirculatory characteristics of meridian phenomena by using an objective assessment tool and investigate the site specificity for the meridian-visceral association and surface-surface association between two specific meridians.

详细描述

The Lung and Heart meridians are chosen as two specific studied meridians. Participants of chronic stable angina pectoris (CSAP) and healthy volunteers will be enrolled.

120 participants will be included and divided into the healthy control group, chronic stable angina pectoris (CSAP) group and healthy intervention group. Laser doppler flowmetry (LDF) will be used to assess the microcirculatory characteristics of meridian phenomena for the Heart and Lung meridians. The site specificity for the meridian-visceral association will be investigated by comparing the microcirculatory difference between the Heart and Lung meridians in the healthy control group and CSAP group. Besides, participants in the healthy intervention group will receive two sessions of moxibustion in the Heart meridian and Lung meridian respectively to explore the site specificity for the surface-surface association.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
20 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Inclusion criteria for the CSAP group
  • Patients should meet the diagnostic criteria of coronary heart disease, which includes the following items: 1)confirmed old myocardial infarction (MI), or a history of percutaneous coronary intervention(PCI), or coronary artery bypass grafting; 2)50% or more luminal stenosis in at least one coronary artery or major branch segment confirmed by coronary angiogram or CT angiography; 3) myocardial ischemia indicted by exercise stress radionuclide myocardial imaging; 4) treadmill exercise testing is positive (for male patients);
  • Patients should meet the diagnostic criteria of CSAP and the Canadian Cardiovascular Society(CCS) classification for CSAP is level II or III;
  • The medical history of CSAP is more than 3 months with attacks occurring at least twice weekly in the last month;
  • 35 ≤ age ≤75 years, male or female;
  • Patients have clear consciousness and could communicate with others normally;
  • Patients could understand the full study protocol and written informed consent is signed.
  • Inclusion criteria for health volunteers
  • Healthy volunteers should provide a recent medical examination report to confirm they have not any cardiovascular, respiratory, digestive, urinary, hematological, endocrine and neurological disease;
  • age≥20 years, male or female;
  • Participants have clear consciousness and could communicate with others normally;
  • Participants could understand the full study protocol and written informed consent is provided by themselves or their lineal kin.

排除标准

  • Exclusion criteria for the CSAP group
  • Patients with acute coronary syndrome and severe arrhythmias;
  • Patients'chest pain is caused by valvular heart disease, hypertrophic cardiomyopathy and dilated cardiomyopathy;
  • Patients'chest pain is caused by non-cardiac disease;
  • Patients have concomitant conditions of lung diseases, such as obstructive pulmonary disease;
  • Patients have serious concomitant conditions and fail to treat them effectively, such as diseases of the digestive, urinary, respiratory, hematological and nervous system;
  • Patients have mental illness, severe depression, alcohol dependence or history of drug abuse;
  • Pregnant or lactating patients;
  • Patients are participating in other trials.
  • Exclusion criteria for health volunteers
  • Participants have mental illness, severe depression, alcohol dependence or history of drug abuse;
  • Pregnant or lactating participants ;
  • Participants are participating in other trials.

结局指标

主要结局

Change from baseline blood perfusion units

时间窗: 5-minute baseline, 15 minutes during moxibustion and 5 minutes after stopping moxibustion

Laser doppler flowmetry is used to assess blood perfusion units of relevant sites along the Heart and Lung meridians

Change from baseline blood flow curve

时间窗: 5-minute baseline, 15 minutes during moxibustion and 5 minutes after stopping moxibustion

Laser doppler flowmetry is used to assess blood flow curve of relevant sites along the Heart and Lung meridians

次要结局

未报告次要终点

研究者

发起方
Zhejiang Chinese Medical University
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Jianqiao Fang

President

Zhejiang Chinese Medical University

研究点 (1)

Loading locations...

相似试验